"We're excited to announce the involvement of Rocky Mountain TMS / TMS Solutions in a clinical study on Adolescent Depression using Transcranial Stimulation", Christopher Blackburn said. With headquarters in Grand Junction, CO, TMS Solutions is in their third year actively treating adult patients, according to Dr. Robert Sammons, psychiatrist and co-founder. "This is quite an honor to selected as part of the group of other prestigious hospitals, institutes and clinics taking part in this study, including the Mayo Clinic,the University of Cincinnati College of Medicine, Ohio State University and the University of Utah Neuropsychiatric Institute and Shephard Pratt to name a few", Blackburn said.
Neuronetics Announces Launch of First Ever Randomized, Controlled Clinical Trial to Evaluate Non-Drug NeuroStar TMS Therapy® in Adolescent Patients with Major Depressive Disorder. This study will Examine Acute and Long-Term Benefits of NeuroStar TMS, Including Symptom Reduction and Remission Rates.
[Press Release: MALVERN, Pa., Nov. 2, 2015]